Navigation Links
Monsanto Announces Key Regulatory Approvals for Roundup Ready 2 Yield(TM) Soybeans; Product Remains on Track for 2009 Launch
Date:7/24/2008

ST. LOUIS, July 24 /PRNewswire-FirstCall/ -- Monsanto Company (NYSE: MON) announced today that it has received regulatory approvals for Roundup Ready 2 Yield(TM) soybeans in Mexico, Australia and New Zealand. In addition, the company noted the European Food Safety Authority (EFSA) has issued a positive scientific opinion concluding Roundup Ready 2 Yield is safe for import as food or feed. Roundup Ready 2 Yield soybeans are the second generation of the popular Roundup Ready(R) technology in soybeans and offer increased yields.

"These regulatory decisions by Mexico and Europe represent significant steps forward in delivering Roundup Ready 2 Yield soybeans to our customers," according to Brett Begemann, Monsanto's executive vice president of global commercial business. "Farmers have used Roundup Ready(R) soybeans for more than 10 years to achieve unsurpassed weed control. Roundup Ready 2 Yield soybeans have increased yields, and will advance farmers' ability to meet the world's growing food, feed and fuel needs."

Roundup Ready 2 Yield soybeans have now been approved in the United States, Canada, Mexico, Taiwan, Japan, the Philippines, Australia and New Zealand, says Jerry Hjelle, Monsanto's regulatory vice president.

"These recent approvals add to the list of countries that have reviewed and concluded that Roundup Ready 2 Yield soybeans are safe," he explains. "The positive EFSA opinion on safety is an important step toward gaining approval within the European Union. Moreover, we are working diligently to achieve regulatory clearance in other markets in anticipation of a 2009 release."

In four years of testing, Roundup Ready 2 Yield soybeans have demonstrated a consistent yield advantage of 7 percent to 11 percent when compared with its predecessor, Roundup Ready soybeans. The four-year average yield increase of Roundup Ready 2 Yield over its first-generation counterpart was 9 percent.

Monsanto's Roundup Ready 2 Yield soybeans
'/>"/>

SOURCE Monsanto Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Monsantos Industry-Leading Seed Position Creates Accelerated Biotech Trait Opportunity in Latin America
2. Monsanto Company and Mendel Biotechnology Announce Cellulosic Biofuels Collaboration
3. Monsanto Executives to Address Investor Conferences in February
4. National Academy of Sciences Recognizes Monsantos Chief Technology Officer for Development of Agricultural Biotechnology
5. Monsantos R&D Pipeline Set to Deliver Valuable Products to Farmers Well Into Next Decade
6. Monsanto and Devgen Describe New Approach to Insect-Protection
7. Monsanto Company Executives Adopt 10b5-1 Trading Plans
8. Science Magazine Recognizes Monsanto as Top Employer
9. Monsanto Sees Record Sales in Fiscal Year 2007; Seeds and Traits Business Contributes to Strong Fourth Quarter and Year-End Results
10. Monsanto Company Sets Webcast and Analyst/Media Call for 2007 Fourth-Quarter and Fiscal-Year Financial Results
11. Monsanto and Evogene Collaborate on Nitrogen Use Efficiency Research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009).../--Sigma-AldrichCorporation(Nasdaq: SIAL )willbepr...1stat1:45PMGMTinLondon,7:45AMUS/CST.Interestedpart...ailableat http://inve s tor.sig m a a ldric...file. ,, AboutSigma-Aldrich: Sigma-Aldrichis...micalandbiochemicalproductsandkitsareusedinscienti...
(Date:11/24/2009)...DPharmaceuticalsInc.announced,theUSPatent&Trad...itsnano-particleoraldeliveryorNODtechnology. ,,...ratepeptidesor,proteinsintobio-adhesivenano-partic...edasinjections.NODtechnologyisaplatformtechnology,...ulin,interferon,growthhormone,exenatide,heparinan...
(Date:11/24/2009)...leEnergyCorp.announcedtodaythatthecompanyandtheOde...rded$2millionbyWashingtonState,sCommunityEconomicR...iptoconstructthestate,sfirstspecialtybiochemicalbi...willsignificantlyspeedthedevelopmentofourbiorefine...MarbleEnergyCEOKellyOgilvie."WearegratefultotheGov...
(Date:11/24/2009).../PRNewswire-FirstCall/-HamiltonThorneLtd.(TSX-V:HT...vancedlasersystemsandinstrumentsforthestemcellrese...onalandfinancialresultsforthethirdquarterendedSept...46millioncomparedwith$1.43millioninQ32008,-Grosspr...3,2008,-Netlossreducedto$148,000comparedto$283,000...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7
.... 28 Beckman,Coulter, Inc. (NYSE: BEC ), announc...ents with Adventist Health to provide a broad rang...t approximately $36 million over,six years. Advent... care,system with facilities in California, Hawaii...scom.com/cgi-bin/prnh/20031202/BECLOGO ), Under t...
...um Drives 71% Year-Over-Year Growth in Core ... Calif., Oct. 28 Cepheid (Nasdaq:,CPHD) today rep....9,million, an increase of 24% over the third quar...$(0.11) per share, which compares to revenue of $3....09) per share, in the third,quarter of fiscal 200...
...ovavax, Inc.,(Nasdaq: NVAX ) a clinical-stage vac...vi, President and Chief Executive Officer, will be... am. (PT) on October 30, 2008 at the,Palace Hotel ...vide an,overview of the company,s strategy, resear...esentation can be accessed via the Company website...
Other Biology Technology:Beckman Coulter Signs Agreements with Adventist Health; Broad Product Offering Enhances Delivery of Quality Patient Care 2Cepheid Reports Third Quarter Revenue of $44.9 Million 2Cepheid Reports Third Quarter Revenue of $44.9 Million 3Cepheid Reports Third Quarter Revenue of $44.9 Million 4Cepheid Reports Third Quarter Revenue of $44.9 Million 5Cepheid Reports Third Quarter Revenue of $44.9 Million 6Cepheid Reports Third Quarter Revenue of $44.9 Million 7Cepheid Reports Third Quarter Revenue of $44.9 Million 8Cepheid Reports Third Quarter Revenue of $44.9 Million 9Cepheid Reports Third Quarter Revenue of $44.9 Million 10Cepheid Reports Third Quarter Revenue of $44.9 Million 11Cepheid Reports Third Quarter Revenue of $44.9 Million 12Cepheid Reports Third Quarter Revenue of $44.9 Million 13
(Date:11/24/2009)...of debate. A high-profile study a few years ago su...arbon from trees and leaves, evidence for a very c...ystems. , But new research from the University o...Algae provide a much richer diet for fish and othe...is week in the Proceedings of the National Academ...
(Date:11/23/2009)...vidence that the "synergistic" effect of early-lif...on and indoor endotoxin causes more harm to develo... , Environmental health scientists at the Univer...hown that children exposed to both high levels of ...ing early life are six times more likely to experi...
(Date:11/23/2009)...of day matters to forest trees dealing with drough... team led by Professor Malcolm Campbell, Universit...arch and colleagues in the department of cell and ...pitalizing on their previous work to decode the ge...d how poplar trees use their 45,000 genes to respo...
Breaking Biology News(10 mins):Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Time of day matters to thirsty trees, U of T researcher discovers 2Atlantic Pharmaceuticals Inc Announces Completion of Successful Pre IND Meeting with FDA for Abuse Deterrent Narcotic 49728 1Atlantic Pharmaceuticals Inc Announces Completion of Successful Pre IND Meeting with FDA for Abuse Deterrent Narcotic 49728 2Austrian IT Solutions Provider x tention IT GmbH Implements Entrust Versatile Authentication Platform 49723 1Austrian IT Solutions Provider x tention IT GmbH Implements Entrust Versatile Authentication Platform 49723 2Austrian IT Solutions Provider x tention IT GmbH Implements Entrust Versatile Authentication Platform 49723 3ThromCat 28R 29 XT 28TM 29 Thrombectomy Catheter System Receives CE Mark 49718 1ThromCat 28R 29 XT 28TM 29 Thrombectomy Catheter System Receives CE Mark 49718 2ThromCat 28R 29 XT 28TM 29 Thrombectomy Catheter System Receives CE Mark 49718 3
...ist has discovered key appetite control cells in t...ased hunger and potentially weight-gain as we grow...oendocrinologist with Monash University,s Departme..., Dr Andrews found that appetite-suppressing cell...aid the degeneration is more significant following...
... many men during their fight against prostate canc...searchers have found. The findings were published ...edings of the National Academy of Sciences . , Th...edeviled patients for decades. Hormone therapy, a ...ncer, generally keeps the cancer at bay for a year...
...s(TM) Wireless Data Communications Link School ..., WALL, N.J., Aug. 20 BIO-key International,Inc....sed biometric,identification and wireless public s...of MobileSRO(TM) and MobileCampus(TM), silent, sec...-12 schools and higher,education, respectively., ...
Other Biology News:Killer carbs -- Monash scientist finds the key to overeating as we age 2Why a common treatment for prostate cancer ultimately fails 2Why a common treatment for prostate cancer ultimately fails 3Why a common treatment for prostate cancer ultimately fails 4BIO-key(R) Announces Emergency Alert and Management Solutions for Schools and Campuses 2BIO-key(R) Announces Emergency Alert and Management Solutions for Schools and Campuses 3
Goat Anti-Human Serpin B5 / Maspin Polyclonal Antibody, Unconjugated from R&D Systems
Rabbit Anti-SOX10 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Rabbit Anti-Human GMNN Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Normal Human Serum from 3H Biomedical AB
Biology Products: